Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2010
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010059922A1 Pyrrolidine carboxamide compounds
05/27/2010WO2010059858A1 Manassantin compounds and methods of making and using same
05/27/2010WO2010059627A1 Polar quinazolines as liver x receptors ( lxrs ) modulators
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058318A1 1-oxa-8-azaspiro [4, 5 ] decane- 8 -carboxamide compounds as faah inhibitors
05/27/2010WO2010057877A1 7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
05/27/2010WO2010057442A1 A optical isomer of benzene propanoic acid and its medicinal use
05/27/2010WO2010057295A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010WO2010039529A3 Compositions and methods for the treament of inflammatory disease
05/27/2010WO2010025430A9 Homeopathic therapeutic method
05/27/2010WO2010017403A3 Therapeutic compositions, devices and methods for observing treated tissues
05/27/2010WO2010017055A3 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
05/27/2010US20100130623 Production of stilbenes in plant hairy root cultures and other root cultures
05/27/2010US20100130613 ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF CD1d OR IL-10
05/27/2010US20100130611 Omega 3 fatty acid formulations
05/27/2010US20100130584 Novel compounds from antrodia camphorata
05/27/2010US20100130563 Inhibitors of plasma kallikrein
05/27/2010US20100130552 Therapeutic Agents Useful for Treating Pain
05/27/2010US20100130542 Composition Comprising a Combination of Omeprazole and Lansoprazole, and a Buffering Agent, and Methods of Using Same
05/27/2010US20100130540 Azaquinolinone derivatives and uses thereof
05/27/2010US20100130506 Organic Compounds
05/27/2010US20100130502 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100129455 Nanoparticle-dispersed fine glass beads having a cavity therein, and method of producing the same
05/27/2010US20100129366 Thiazole inhibitors of cyclooxygenase
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
05/27/2010US20100129296 Extract of trigonella foenum-graecum
05/27/2010CA2743967A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010CA2742023A1 Polar quinazolines as liver x receptors ( lxrs ) modulators
05/27/2010CA2741839A1 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010EP2189439A2 CaSR antagonist
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2187900A2 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
05/26/2010EP2187866A2 Dexamethasone formulations in a biodegradable material
05/26/2010EP1575379B1 Nutritional compositions
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1497278B1 Heterocyclic amide derivatives as cytokine inhibitors
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010CN1951494B Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof
05/26/2010CN1951483B Hybrid safflower oil and preparation method thereof
05/26/2010CN1930180B L-saccharide glucose lipid A analogue
05/26/2010CN1899401B Three ingredient body comfort liquid
05/26/2010CN1875997B Application of sundew in pharmaceutical preparation
05/26/2010CN1827107B Substained analgesia achieved with buprenorphine
05/26/2010CN1799557B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1711282B Inhibition of Il-17 production
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1678744B Human antihuman interleukin-6 antibody and fragment of the antibody
05/26/2010CN1665507B Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
05/26/2010CN1660832B Method for extracting and separating general flavone and saponin astragalus root from astragalus root
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101715453A heterocyclic compounds and their uses
05/26/2010CN101715441A Quinoline derivatives as CRTH2 receptor ligands
05/26/2010CN101712957A Toll-like receptor 9 (TLR9) blocking agent and application thereof
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101711862A Medicine target spot relevant to inflammatory diseases and application thereof
05/26/2010CN101711856A Oral liquid for cold
05/26/2010CN101711849A Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method
05/26/2010CN101711835A Formula of traditional Chinese medicines for treating soft tissue injury and method for preparing preparation thereof
05/26/2010CN101711807A Antiphlogistic and antibiotic ointment
05/26/2010CN101711806A Medicine for treating rheumatoid arthritis and preparation method thereof
05/26/2010CN101711805A Medicine composition for treating rheumatoid arthritis and preparation thereof
05/26/2010CN101711801A Natural galenical preparation for preventing and treating blue-ear disease and hyperpyrexia of unknown origin and preparation method thereof
05/26/2010CN101711799A Externally-applied powder used for midwifery of piglets
05/26/2010CN101711795A Veterinary antipyretic and antiviral medicine composite
05/26/2010CN101711788A Anti-inflammatory analgesic medicament and preparation method thereof
05/26/2010CN101711760A Thiophene derivative with excellent function of blood glucose reduction and adduct PPAR alpha/gamma double agonists thereof
05/26/2010CN101711740A Method for preparing targeted curcumin nanoparticles for treating ulcerative colitis
05/26/2010CN101099854B External-applied traditional Chinese medicine preparation for treating rheumatism pain disease and preparing method
05/26/2010CN101081092B beverage for expelling toxin and treating melancholy
05/26/2010CN101062377B Adhesive plaster for diminishing inflammation, expelling wind and cold
05/26/2010CN101050170B New type natural active compound for anti tumor, preparation method, and application
05/26/2010CN101049352B Method for preparing short-pedicel aconite root of Chinese traditional medicine
05/26/2010CN101040927B Chinese traditional medicine compound took orally for treating ankylosing spondylitis
05/26/2010CN101023772B Gastrodia-walnut health-care sweet
05/26/2010CN101003528B Diterpene compound and derivative in kaurene class of new dissymmetry, and its preparation method and uses
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723492 Method for the detection of sepsis using procalcitonin-3-116
05/25/2010US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723389 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/25/2010US7723370 P-3-(trifluoromethyl)-5-(p-tolyl)pyrazol-1-yl)benzenesulonylaminooxy- compounds; more effective than celecoxib and have fewer gastrointestinal and cardiovascular side effects; 4-(5-p-methyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonic acid intermediate
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 1272